Background Troglitazone is a new oral antidiabetic drug that increases the sensitivity of peripheral tissues to insulin. It may therefore increase the efficacy of exogenous insulin in patients with insulin-resistant diabetes mellitus.Methods We studied the effect of troglitazone or placebo in 350 pa...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!